openPR Logo
Press release

Fanconi Anemia Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis

04-06-2025 04:44 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Fanconi Anemia Market

Fanconi Anemia Market

DelveInsight's "Fanconi Anemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fanconi Anemia, historical and forecasted epidemiology as well as the Fanconi Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

Discover Key Insights into the Fanconi Anemia Market with DelveInsight's In-Depth Report @ Fanconi Anemia Market Size- https://www.delveinsight.com/sample-request/fanconi-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Fanconi Anemia Market Report
• In 2023, the combined diagnosed prevalent cases of Fanconi Anemia in the EU4 countries and the UK amounted to approximately 3 thousand. Over the study duration, a significant rise in cases is expected across all participating nations. Among the EU4 countries, Germany recorded the highest proportion of Fanconi Anemia cases, whereas Spain reported the fewest cases.
• The estimates show the Total Diagnosed Prevalent Cases of Fanconi Anemia in Japan was found to be around 1.1 thousand in 2023, which is estimated to increase by 2034.
• Based on DelveInsight's analysis, experts categorized the Mutation-specific Cases of Fanconi Anemia according to specific mutations, including FANCA, FANCC+FANCG, FANCE+FANCF, and others. In 2023, the FANCA category accounted for the highest number of cases, approximately 2 thousand, in the United States.
• In 2023, cases of Comorbidity associated with Fanconi Anemia were categorized into Hematological disease, Hematological malignancy, and Solid tumors. The highest number of cases, totaling 2.8 thousand, were attributed to Hematological disease in the US.
• The leading Fanconi Anemia Companies such as Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis, and others
• Promising Fanconi Anemia Therapies such as RP-L102, FP-045, PS191, Deferasirox, and others

Stay ahead in the Fanconi Anemia Therapeutics Market with DelveInsight's Strategic Report @ Fanconi Anemia Market Outlook- https://www.delveinsight.com/sample-request/fanconi-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Fanconi Anemia Epidemiology Segmentation in the 7MM
• Total Fanconi Anemia Prevalence
• Prevalent Cases of Fanconi Anemia by severity
• Fanconi Anemia Gender-specific Prevalence
• Fanconi Anemia Diagnosed Cases of Episodic and Chronic

Download the report to understand which factors are driving Fanconi Anemia epidemiology trends @ Fanconi Anemia Prevalence- https://www.delveinsight.com/sample-request/fanconi-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Fanconi Anemia Emerging Drugs
• RP-L102 (lentiviral gene therapy): Rocket Pharmaceuticals
RP-L102 is a gene therapy under development for treating Fanconi Anemia, utilizing a lentiviral vector (LVV). This therapy carries the FANC-A gene within the PGK-FANCA-WPRE expression cassette, incorporating a phosphoglycerate kinase (PKG) promoter and an optimized woodchuck hepatitis virus post-transcriptional regulatory element (WPRE). Through an ex vivo process, hematopoietic stem cells are extracted and enriched using CD34+ selection. These genetically modified CD34+ enriched hematopoietic cells, either fresh or cryopreserved, are then reintroduced into patients to restore function. RP-L102 has received various designations, including ODD, RPDD, FTD, and RMAT designation in the United States, as well as ODD and PRIME status in Europe. Moreover, the EMA has classified this therapy as an ATMP.

• FP-045: Foresee Pharmaceuticals
FP-045 is a potent and specifically targeted activator of aldehyde dehydrogenase 2 (ALDH2), characterized by high solubility and oral availability. ALDH2 serves as a crucial mitochondrial regulator involved in metabolizing harmful aldehydes, particularly those generated during ethanol metabolism and oxidative stress. Moreover, FP-045 has demonstrated the ability to enhance ALDH2 activity in vitro within FANCA-deficient cells, offering protection against damage caused by exposure to reactive aldehydes.

Fanconi Anemia Market Outlook
Fanconi Anemia treatment encompasses various classifications within the disease spectrum. The primary focus of managing Fanconi Anemia involves the use of Androgen Therapy and Maintenance Therapies as required, with Androgen Therapy serving as the principal revenue source in the current treatment framework. The market for Fanconi Anemia is expected to experience positive growth with the approval of potential drugs like LV RP-L102, FP-045, and others. In 2023, the overall market value of Fanconi Anemia across the 7MM was approximately USD 51 million. Forecasts suggest significant expansion in the market size throughout the projected period.

Get In-Depth Knowledge on Fanconi Anemia Market Trends and Forecasts with DelveInsight @ Fanconi Anemia Treatment Market- https://www.delveinsight.com/sample-request/fanconi-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Fanconi Anemia Market Strengths
• Fanconi anemia is a rare disease; thus, companies developing treatment options for the same can possess several advantages like market exclusivities, premium pricing, subsidy for conducting trials, and several other benefits from the government bodies for R&D.

Fanconi Anemia Market Opportunities
• There is a huge opportunity for companies coming up with therapies as there will be fewer competition in the market. If the drugs are launched they will be in huge demand keeping in mind the unmet needs for this indication.

Scope of the Fanconi Anemia Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Fanconi Anemia Companies: Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis, and others
• Fanconi Anemia Therapies: RP-L102, FP-045, PS191, Deferasirox, and others
• Fanconi Anemia Therapeutic Assessment: Fanconi Anemia current marketed and Fanconi Anemia emerging therapies
• Fanconi Anemia Market Dynamics: Fanconi Anemia market drivers and Fanconi Anemia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Fanconi Anemia Unmet Needs, KOL's views, Analyst's views, Fanconi Anemia Market Access and Reimbursement

Unlock Strategic Insights with DelveInsight's Comprehensive Fanconi Anemia Market Report @ Fanconi Anemia Market Drivers and Barriers- https://www.delveinsight.com/sample-request/fanconi-anemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Fanconi Anemia Market Report Introduction
2. Executive Summary for Fanconi Anemia
3. SWOT analysis of Fanconi Anemia
4. Fanconi Anemia Patient Share (%) Overview at a Glance
5. Fanconi Anemia Market Overview at a Glance
6. Fanconi Anemia Disease Background and Overview
7. Fanconi Anemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Fanconi Anemia
9. Fanconi Anemia Current Treatment and Medical Practices
10. Fanconi Anemia Unmet Needs
11. Fanconi Anemia Emerging Therapies
12. Fanconi Anemia Market Outlook
13. Country-Wise Fanconi Anemia Market Analysis (2020-2034)
14. Fanconi Anemia Market Access and Reimbursement of Therapies
15. Fanconi Anemia Market Drivers
16. Fanconi Anemia Market Barriers
17. Fanconi Anemia Appendix
18. Fanconi Anemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

List of Top Selling Market Research Reports in 2025

Autosomal Dominant Polycystic Kidney Disease Market- https://www.delveinsight.com/report-store/autosomal-dominant-polycystic-kidney-disease-market
Familial Lipoprotein Lipase Deficiency Pipeline- https://www.delveinsight.com/report-store/familial-lipoprotein-lipase-deficiency-pipeline-insight
Frontotemporal Dementia Pipeline- https://www.delveinsight.com/report-store/frontotemporal-dementia-pipeline-insight
Human Papillomavirus-positive Oropharyngeal Cancer Market- https://www.delveinsight.com/report-store/human-papillomavirus-positive-oropharyngeal-cancer-market
Moderate And Severe Chronic Kidney Disease Market- https://www.delveinsight.com/report-store/chronic-kidney-disease-chronic-renal-failure-market
Monoclonal Gammopathy Of Undetermined Significance Market- https://www.delveinsight.com/report-store/monoclonal-gammopathy-of-undetermined-significance-market
Myopia Treatment Devices Market- https://www.delveinsight.com/report-store/myopia-treatment-devices-market
Myotonic Dystrophy Market- https://www.delveinsight.com/report-store/myotonic-dystrophy-market
Neurodermatitis Market- https://www.delveinsight.com/report-store/neurodermatitis-market
Osteochondrodysplasia Market- https://www.delveinsight.com/report-store/osteochondrodysplasia-market
Peptic Ulcer Hemorrhage Market- https://www.delveinsight.com/report-store/peptic-ulcer-hemorrhage-market
Perivascular Epithelioid Cell Tumor Market- https://www.delveinsight.com/report-store/perivascular-epithelioid-cell-tumor-market
Plasmodium Vivax Malaria Market- https://www.delveinsight.com/report-store/plasmodium-vivax-malaria-market
Thymidine Kinase 2 Deficiency Market- https://www.delveinsight.com/report-store/thymidine-kinase-2-deficiency-tk2d-market
Xlinked Severe Combined Immunodeficiency Market- https://www.delveinsight.com/report-store/xlinked-severe-combined-immunodeficiency-scid-market
Chagas Disease Market - https://www.delveinsight.com/report-store/chagas-disease-market
Diabetes Insipidus Market- https://www.delveinsight.com/report-store/diabetes-insipidus-market
Geographic Atrophy Market- https://www.delveinsight.com/report-store/geographic-atrophy-ga-market
Peanut Allergy Market Report- https://www.delveinsight.com/report-store/peanut-allergy-market
Postherpetic Neuralgia Market- https://www.delveinsight.com/report-store/postherpetic-neuralgia-market
Pouchitis Market- https://www.delveinsight.com/report-store/pouchitis-market
Presbyopia Market- https://www.delveinsight.com/report-store/presbyopia-market
Prostate Cancer Market- https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Refractory Metastatic Melanoma Market- https://www.delveinsight.com/report-store/refractory-metastatic-melanoma-market
Rubella Market- https://www.delveinsight.com/report-store/rubella-market
Smoking Cessation And Nicotine Addiction Market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
Systemic Inflammatory Response Syndrome Market- https://www.delveinsight.com/report-store/systemic-inflammatory-response-syndrome-market
Systemic Inflammatory Response Syndrome Market Insights- https://www.delveinsight.com/report-store/systemic-inflammatory-response-syndrome-market
Uveal Melanoma Market- https://www.delveinsight.com/report-store/ocular-melanoma-market
Wiskott-aldrich Syndrome Market- https://www.delveinsight.com/report-store/wiskott-aldrich-syndrome-market
Adult T-cell Leukemia-lymphoma Market- https://www.delveinsight.com/report-store/adult-t-cell-leukemia-lymphoma-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Asperger Syndrome Market- https://www.delveinsight.com/report-store/asperger-syndrome-market
House Dust Mite Allergy Market- https://www.delveinsight.com/report-store/house-dust-mite-allergy-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Keloid Market- https://www.delveinsight.com/report-store/keloid-market
Pcsk9 Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-psck9i-market
Peripheral Nerve Repair Devices Market- https://www.delveinsight.com/report-store/peripheral-nerve-repair-devices-market
Sarcopenia Market- https://www.delveinsight.com/report-store/sarcopenia-market
Skin Neoplasm Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Vascular Imaging Devices Market- https://www.delveinsight.com/report-store/vascular-imaging-market-market
Venous Ulcer Market- https://www.delveinsight.com/report-store/venous-leg-ulcer-market
Cardiogenic Shock Market- https://www.delveinsight.com/report-store/cardiogenic-shock-market
Herpes Labialis Market- https://www.delveinsight.com/report-store/herpes-labialis-market
Meningococcal Meningitis Market- https://www.delveinsight.com/report-store/meningococcal-meningitis-market
Septic Shock Market- https://www.delveinsight.com/report-store/septic-shock-market
Transmucosal Drug Delivery Devices Market- https://www.delveinsight.com/report-store/transmucosal-drug-delivery-devices-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-tumor-market
Cone Rod Dystrophy Market- https://www.delveinsight.com/report-store/cone-rod-dystrophy-market
Orthopedic Power Devices Market- https://www.delveinsight.com/report-store/orthopedic-power-devices-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Short Bowel Syndrome Drug Market- https://www.delveinsight.com/report-store/short-bowel-syndrome-market
Spinal Trauma Devices Market- https://www.delveinsight.com/report-store/spinal-trauma-devices-market-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Tcr Therapy Market- https://www.delveinsight.com/report-store/tcr-therapy-market
Heart Failure Market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
Surgical Robotic System Market- https://www.delveinsight.com/report-store/surgical-robotic-system-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Indwelling Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fanconi Anemia Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | Rocket Pharma, Foresee Pharmaceuticals, Jasper Therapeutics, Novartis here

News-ID: 3957042 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Fanconi

Fanconi Anemia Market Innovations, Key Players and Growth Opportunities
Fanconi Anemia (FA) is a rare, inherited disorder that leads to bone marrow failure, chromosomal instability, and an increased risk of cancers. FA is typically diagnosed in children and can lead to severe complications such as leukemia, solid tumors, and growth abnormalities. This condition is caused by mutations in specific genes responsible for DNA repair, leading to defective cell functioning and high levels of genetic damage. Individuals with FA often
Renal Fanconi Syndrome Market Forecast 2025-2034: Comprehensive Analysis And Gro …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Renal Fanconi Syndrome Market? In recent times, the market size for renal fanconi syndrome has experienced sustained growth. The market is forecasted to increase from $0.53 billion in 2024 to $0.55 billion in 2025, with a compound annual growth rate (CAGR) of 4.0%. Several factors
Fanconi Anemia Treatment Market: Navigating Rare Disease Therapeutics
The fanconi anemia treatment market was valued at approximately USD 1.5 billion in 2023 and is expected to reach USD 3.2 billion by 2033, growing at a CAGR of around 8.1% from 2024 to 2033. The Fanconi Anemia (FA) treatment market represents a specialized segment within the rare disease therapeutics landscape, characterized by significant unmet medical needs and emerging therapeutic innovations. Fanconi Anemia, a rare inherited bone marrow failure syndrome affecting
Fanconi Anemia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Fanconi Anemia Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Fanconi Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Fanconi Anemia Research. Learn more about
Fanconi Anemia Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "Fanconi Anemia Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly studies current
Renal Fanconi Syndrome Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Renal Fanconi Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Renal Fanconi Syndrome, historical and forecasted epidemiology as well as the Renal Fanconi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Renal Fanconi Syndrome market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Renal